Constellation Pharmaceuticals to be Acquired by MorphoSys Portfolio News / By Karina Tin June 2, 2021 Constellation Pharmaceuticals to be Acquired by MorphoSys Read More »
Nurix Therapeutics Announces Presentation of Preclinical Data from NX-5948 Program Demonstrating Significant Reduction of Inflammation in a Model of Autoimmune Disease Portfolio News / By Karina Tin June 2, 2021 Nurix Therapeutics Announces Presentation of Preclinical Data from NX-5948 Program Demonstrating Significant Reduction of Inflammation in a Model of Autoimmune Disease Read More »
Kallyope Inc. Appoints Patrick Flanigan as Chief Financial Officer Portfolio News / By Karina Tin June 1, 2021 Kallyope Inc. Appoints Patrick Flanigan as Chief Financial Officer Read More »
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies Portfolio News / By Karina Tin May 27, 2021 eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies Read More »
Surrozen Presents Data from Lead Wnt-Modulating Antibody Programs, SZN-1326 and SZN-043, in Six Oral and Poster Presentations at 2021 Digestive Disease Week Conference Portfolio News / By Karina Tin May 24, 2021 Surrozen Presents Data from Lead Wnt-Modulating Antibody Programs, SZN-1326 and SZN-043, in Six Oral and Poster Presentations at 2021 Digestive Disease Week Conference Read More »
NGM Bio Reports Topline Results from 24-Week Phase 2b ALPINE 2/3 Study of Aldafermin in NASH Portfolio News / By Karina Tin May 24, 2021 NGM Bio Reports Topline Results from 24-Week Phase 2b ALPINE 2/3 Study of Aldafermin in NASH Read More »
Tenaya Therapeutics Receives Orphan Drug Designation and Presents Pre-Clinical Data for its Most Advanced Gene Therapy Product Candidate for Genetic Hypertrophic Cardiomyopathy Portfolio News / By Karina Tin May 20, 2021 Tenaya Therapeutics Receives Orphan Drug Designation and Presents Pre-Clinical Data for its Most Advanced Gene Therapy Product Candidate for Genetic Hypertrophic Cardiomyopathy Read More »
Escient Pharmaceuticals Appoints Christian Weyer, M.D., M.A.S., As President And Chief Medical Officer Portfolio News / By Karina Tin May 17, 2021 Escient Pharmaceuticals Appoints Christian Weyer, M.D., M.A.S., As President And Chief Medical Officer Read More »
RAPT Therapeutics Reports First Quarter 2021 Financial Results Portfolio News / By Karina Tin May 11, 2021 RAPT Therapeutics Reports First Quarter 2021 Financial Results Read More »
Revolution Medicines Reports First Quarter Financial Results and Update on Corporate Progress Portfolio News / By Karina Tin May 10, 2021 Revolution Medicines Reports First Quarter Financial Results and Update on Corporate Progress Read More »
